Van Echo DA - Search Results

1

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.

Aisner J, Whitacre MY, Budman DR, Propert K, Strauss G, Van Echo DA, Perry M. Aisner J, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 1992;29(6):435-8. doi: 10.1007/BF00684843. Cancer Chemother Pharmacol. 1992. PMID: 1314712 Clinical Trial.

2

Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.

Aisner J, Whitacre M, VanEcho DA, Wesley M, Wiernik PH. Aisner J, et al. Cancer Chemother Pharmacol. 1982;7(2-3):187-93. doi: 10.1007/BF00254546. Cancer Chemother Pharmacol. 1982. PMID: 6282482 Clinical Trial.

3

A phase I trial of continuous infusion VP16-213 (etoposide).

Aisner J, Van Echo DA, Whitacre M, Wiernik PH. Aisner J, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 1982;7(2-3):157-60. doi: 10.1007/BF00254539. Cancer Chemother Pharmacol. 1982. PMID: 7083457

4

Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin.

Conley BA, Egorin MJ, Whitacre MY, Carter DC, Zuhowski EG, Van Echo DA. Conley BA, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 1993;33(2):107-12. doi: 10.1007/BF00685327. Cancer Chemother Pharmacol. 1993. PMID: 8261569 Clinical Trial.

5

Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B study.

Hargis JB, Anderson JR, Propert KJ, Green MR, Van Echo DA, Weiss RB. Hargis JB, et al. Among authors: van echo da. Cancer Chemother Pharmacol. 1992;30(4):291-6. doi: 10.1007/BF00686298. Cancer Chemother Pharmacol. 1992. PMID: 1643697 Clinical Trial.

6

A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.

Eisenberger M, Krasnow S, Ellenberg S, Silva H, Abrams J, Sinibaldi V, Van Echo D, Aisner J. Eisenberger M, et al. J Clin Oncol. 1989 Sep;7(9):1341-5. doi: 10.1200/JCO.1989.7.9.1341. J Clin Oncol. 1989. PMID: 2671289 Clinical Trial.

7

Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.

Belani CP, Eisenberger M, Van Echo D, Hiponia D, Aisner J. Belani CP, et al. Cancer Treat Rep. 1987 Nov;71(11):1099-100. Cancer Treat Rep. 1987. PMID: 2824047 No abstract available.

8

Carboplatin: the experience in head and neck cancer.

Eisenberger M, Van Echo D, Aisner J. Eisenberger M, et al. Semin Oncol. 1989 Apr;16(2 Suppl 5):34-41. Semin Oncol. 1989. PMID: 2655096 Review. No abstract available.

9

A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.

Belani CP, Egorin MJ, Abrams JS, Hiponia D, Eisenberger M, Aisner J, Van Echo DA. Belani CP, et al. Among authors: van echo da. J Clin Oncol. 1989 Dec;7(12):1896-902. doi: 10.1200/JCO.1989.7.12.1896. J Clin Oncol. 1989. PMID: 2555452

10

Phase II trial of N-methylformamide in advanced renal cancer.

Abrams JS, Tait N, Silva H, Eisenberger M, Van Echo DA, Olver IN, Aisner J. Abrams JS, et al. Among authors: van echo da. Am J Clin Oncol. 1989 Feb;12(1):41-2. doi: 10.1097/00000421-198902000-00009. Am J Clin Oncol. 1989. PMID: 2912020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters